Literature DB >> 18507925

Vibrio cholerae O1 hybrid El Tor strains, Asia and Africa.

Ashrafus Safa, Jinath Sultana, Phung Dac Cam, James C Mwansa, Richard Y C Kong.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18507925      PMCID: PMC2600311          DOI: 10.3201/eid1406.080129

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Vibrio cholerae is a water-borne pathogen that causes a severe watery diarrhea disease known as cholera. On the basis of variable somatic O antigen composition, >200 serogroups of V. cholerae have been recognized. Classical and El Tor are 2 well-established biotypes within the V. cholerae O1 serogroup, and they can be distinguished by differences in their biochemical reactions or phenotypic traits (). In addition to phenotypic traits, genetic markers have recently been used in the identification of the biotypes of V. cholerae. For example, the major toxin-coregulated pilus (TCP) gene, tcpA, of the TCP cluster possesses classical- and El Tor–specific alleles that encode identical functions but differ in their DNA sequence composition; however, the rtxC gene of the repeat in toxin (RTX) cluster is present in El Tor strains only and absent in classical strains (,). The cholera toxin, encoded by the ctxA and ctxB genes, is the principal toxin produced by V. cholerae O1 and O139 and is responsible for the disease cholera. Heterogeneity within the ctxB gene and protein was first reported in the early 1990s, and, on this basis, 3 ctxB genotypes of the V. cholerae O1 strains have been identified. Based on amino acid residue substitutions at positions 39, 46, and 68, all classical and US Gulf Coast El Tor strains have been categorized as genotype 1, the Australian El Tor strains as genotype 2, and the El Tor strains of the seventh pandemic and the Latin American epidemic as genotype 3. Genotyping of ctxB has indicated that the classical strains harbor a unique cholera toxin gene that is not in the El Tor strains except for the US Gulf Coast El Tor clone (). The US Gulf Coast hybrid El Tor strains that harbor the classical cholera toxin have been associated with sporadic outbreaks in the United States () and, until recently, had not been reported anywhere else in the world. Then in 2004, hybrid El Tor strains that encode the classical cholera toxin were isolated from cholera patients in Matlab, Bangladesh (), and in Beira, Mozambique (). In 2006, Nair et al. reported that the current seventh pandemic prototype El Tor strains had been replaced by hybrid El Tor strains in Bangladesh (). We now report how far the hybrid El Tor strains have spread in Asia and Africa. We examined 41 clinical V. cholerae strains from Asia and Africa that were isolated from 1991 through 2004 (Table) and confirmed as serogroup O1 by O-antigen biosynthesis gene (rfbO1)-specific PCR. Biotyping was performed by using standard procedures, and all strains were confirmed as El Tor (Table). All strains were PCR-positive for the El Tor–specific 451-bp tcpA and 263-bp rtxC amplicons but negative for the classical-specific 620-bp tcpA amplicon. All 41 strains were PCR-positive for ctxAB (1,037 bp) and produced cholera toxin, as demonstrated by the VET-RPLA Toxin Detection Kit (Oxoid, Basingstoke, UK). Sequence comparison of the PCR-amplified ctxB gene (460 bp) of each strain with the reference strains (569B and N16961) showed that 30 strains harbored classical cholera toxin (with histidine at position 39, phenylalanine at position 46, and threonine at position 68), whereas the remaining 11 strains carried the El Tor cholera toxin gene (with tyrosine at position 39, phenylalanine at position 46, and isoleucine at position 68) (Table). The overall analysis showed that all test strains are El Tor biotype but that most harbor the classical cholera toxin gene.
Table

Phenotypic and genotypic traits of Vibrio cholerae O1 clinical strains isolated from Asia and Africa, 1991–2004*

Test strain origin (no. examined) or reference strain IDYear(s) of isolation rfbO1 Phenotypic tests
PCR amplicons
Cholera toxin type† (no. strains)
CCAPolymyxin B (50 U)Voges-ProskauertcpA
(El Tor)tcpA (classical) rtxC
Japan (6)1991–1997++Resistant+++Classical (5), 
El Tor (1)
Hong Kong (18)1998–2000++Resistant+++Classical (11), 
El Tor (7)
Zambia (8)1996–2004++Resistant+++Classical (5), 
El Tor (3)
China (3)1999++Resistant+++Classical (3), 
El Tor (0)
Sri Lanka (1)1998++Resistant+++Classical (1), 
El Tor (0)
Vietnam (5)1994–2002++Resistant+++Classical (5), 
El Tor (0)
Classical 569B1948+Sensitive+Classical
El Tor N169611971++Resistant+++El Tor

*rfbO1, O-antigen biosynthesis genes; CCA, chicken cell agglutination; tcp, toxin-coregulated pilus; rtx, repeat in toxin.
†Based on ctxB sequence. GenBank accession nos. for the ctxB sequences are EU156448–EU156488.

*rfbO1, O-antigen biosynthesis genes; CCA, chicken cell agglutination; tcp, toxin-coregulated pilus; rtx, repeat in toxin.
†Based on ctxB sequence. GenBank accession nos. for the ctxB sequences are EU156448–EU156488. The major finding of this study is that El Tor strains that harbor the classical cholera toxin gene are not limited to the US Gulf Coast, Bangladesh, and Mozambique; they have spread to several other countries in Asia and Africa. Since 1817, 7 cholera pandemics have occurred around the world. Firm evidence indicates that the fifth and sixth cholera pandemics were caused by the classical biotype whereas the most extensive and ongoing seventh pandemic is caused by the El Tor biotype. Since the onset of El Tor dominance in 1961, the classical strains have been gradually replaced by the El Tor strains and are now believed to be extinct. However, reports from Bangladesh (), Mozambique (), and this study have provided sufficient evidence to indicate that the classical cholera toxin gene has reappeared but that for these cases its carrier has been El Tor. Although how the classical cholera toxin in El Tor strains would affect V. cholerae pathogenicity is unclear, cholera caused by the classical biotype is more severe, whereas the El Tor biotype is considered to be better able to survive in the environment (,). Given that cholera toxin is directly responsible for the major clinical sign of the disease, such a genetic change could result in substantial alteration in the clinical manifestation of cholera. Additionally, this subtle genetic change may also influence the effectiveness of current cholera vaccines, which could stimulate both antitoxic and antibacterial immunity.
  8 in total

1.  Genetic characteristics of Matlab variants of Vibrio cholerae O1 that are hybrids between classical and El Tor biotypes.

Authors:  Ashrafus Safa; N A Bhuyian; Suraia Nusrin; M Ansaruzzaman; Munirul Alam; T Hamabata; Yoshifumi Takeda; David A Sack; G Balakrish Nair
Journal:  J Med Microbiol       Date:  2006-11       Impact factor: 2.472

2.  Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains.

Authors:  O Olsvik; J Wahlberg; B Petterson; M Uhlén; T Popovic; I K Wachsmuth; P I Fields
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

Review 3.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

4.  Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh.

Authors:  G Balakrish Nair; Firdausi Qadri; Jan Holmgren; Ann-Mari Svennerholm; Ashrafus Safa; Nurul A Bhuiyan; Q Shafi Ahmad; Shah M Faruque; A S G Faruque; Yoshifumi Takeda; David A Sack
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

Review 5.  Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae.

Authors:  S M Faruque; M J Albert; J J Mekalanos
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

6.  Biotype-specific tcpA genes in Vibrio cholerae.

Authors:  J R Iredell; P A Manning
Journal:  FEMS Microbiol Lett       Date:  1994-08-01       Impact factor: 2.742

7.  Identification of a vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage.

Authors:  W Lin; K J Fullner; R Clayton; J A Sexton; M B Rogers; K E Calia; S B Calderwood; C Fraser; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

8.  Cholera in Mozambique, variant of Vibrio cholerae.

Authors:  M Ansaruzzaman; N A Bhuiyan; Balakrish G Nair; David A Sack; Marcelino Lucas; Jacqueline L Deen; Julia Ampuero; Claire-Lise Chaignat
Journal:  Emerg Infect Dis       Date:  2004-11       Impact factor: 6.883

  8 in total
  55 in total

1.  Cholera epidemic in and around kolkata, India: endemicity and management.

Authors:  Shyamapada Mandal
Journal:  Oman Med J       Date:  2011-07

Review 2.  New-generation vaccines against cholera.

Authors:  John Clemens; Sunheang Shin; Dipika Sur; G Balakrish Nair; Jan Holmgren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-08       Impact factor: 46.802

3.  Cholera toxin production by the El Tor variant of Vibrio cholerae O1 compared to prototype El Tor and classical biotypes.

Authors:  J Ghosh-Banerjee; M Senoh; T Takahashi; T Hamabata; S Barman; H Koley; A K Mukhopadhyay; T Ramamurthy; S Chatterjee; M Asakura; S Yamasaki; G B Nair; Y Takeda
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

4.  A cholera outbreak of the Vibrio cholerae O1 El Tor variant carrying classical CtxB in northeastern Thailand in 2007.

Authors:  Kazuhisa Okada; Siriporn Chantaroj; Amonrattana Roobthaisong; Shigeyuki Hamada; Pathom Sawanpanyalert
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

5.  Occurrence in Mexico, 1998-2008, of Vibrio cholerae CTX+ El Tor carrying an additional truncated CTX prophage.

Authors:  Munirul Alam; Shah Manzur Rashed; Shahnewaj Bin Mannan; Tarequl Islam; Marcial Leonardo Lizarraga-Partida; Gabriela Delgado; Rosario Morales-Espinosa; Jose Luis Mendez; Armando Navarro; Haruo Watanabe; Makoto Ohnishi; Nur A Hasan; Anwar Huq; R Bradley Sack; Rita R Colwell; Alejandro Cravioto
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

6.  Characterization of Vibrio cholerae O1 El Tor biotype variant clinical isolates from Bangladesh and Haiti, including a molecular genetic analysis of virulence genes.

Authors:  Mike S Son; Christina J Megli; Gabriela Kovacikova; Firdausi Qadri; Ronald K Taylor
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

7.  Integration and visualization of host-pathogen data related to infectious diseases.

Authors:  Timothy Driscoll; Joseph L Gabbard; Chunhong Mao; Oral Dalay; Maulik Shukla; Clark C Freifeld; Anne Gatewood Hoen; John S Brownstein; Bruno W Sobral
Journal:  Bioinformatics       Date:  2011-06-27       Impact factor: 6.937

8.  Genome sequence of hybrid Vibrio cholerae O1 MJ-1236, B-33, and CIRS101 and comparative genomics with V. cholerae.

Authors:  Christopher J Grim; Nur A Hasan; Elisa Taviani; Bradd Haley; Jongsik Chun; Thomas S Brettin; David C Bruce; J Chris Detter; Cliff S Han; Olga Chertkov; Jean Challacombe; Anwar Huq; G Balakrish Nair; Rita R Colwell
Journal:  J Bacteriol       Date:  2010-03-26       Impact factor: 3.490

9.  Molecular characterization of Vibrio cholerae outbreak strains with altered El Tor biotype from southern India.

Authors:  A K Goel; M Jain; P Kumar; S C Jiang
Journal:  World J Microbiol Biotechnol       Date:  2009-09-18       Impact factor: 3.312

10.  Hybrid El Tor Vibrio cholerae O1, Kuwait.

Authors:  Rajinder M Joshi; M John Albert
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.